Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: Data from studies conducted in endemic areas show that chemotherapeutic interventions can reduce prevalence and intensity of infection with intestinal helminths, and have the potential to reduce transmission within populations. However, consistent benefits in high-risk groups, including children and pregnant women, have not been established. The long-term benefits of MDA remain to be determined, and the potential for emerging resistance to impact effectiveness have not yet been defined. CONCLUSIONS: Whereas studies evaluating MDA have shown benefit in certain populations, intensive monitoring and evaluation, as well as a commitment of resources for new drug development, are essential for long-term control or elimination of intestinal helminth infections.
|
Authors | Debbie Humphries, Sara Nguyen, Daniel Boakye, Michael Wilson, Michael Cappello |
Journal | Current opinion in infectious diseases
(Curr Opin Infect Dis)
Vol. 25
Issue 5
Pg. 584-9
(Oct 2012)
ISSN: 1473-6527 [Electronic] United States |
PMID | 22903231
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
|
Topics |
- Anthelmintics
(administration & dosage, adverse effects)
- Cost of Illness
- Global Health
- Helminthiasis
(epidemiology, prevention & control)
- Humans
- Intestinal Diseases
(epidemiology, prevention & control)
- Intestinal Diseases, Parasitic
|